These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33258970)

  • 21. Sex differences over time for glycemic control, pump use and insulin dose in patients aged 10-40 years with type 1 diabetes: a diabetes registry study.
    Boettcher C; Tittel SR; Meissner T; Gohlke B; Stachow R; Dost A; Wunderlich S; Lowak I; Lanzinger S
    BMJ Open Diabetes Res Care; 2021 Dec; 9(2):. PubMed ID: 34969693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study.
    Johnson SR; Cooper MN; Jones TW; Davis EA
    Diabetologia; 2013 Nov; 56(11):2392-400. PubMed ID: 23963323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017.
    van den Boom L; Karges B; Auzanneau M; Rami-Merhar B; Lilienthal E; von Sengbusch S; Datz N; Schröder C; Kapellen T; Laimer M; Schmid SM; Müller H; Wolf J; Holl RW
    Diabetes Care; 2019 Nov; 42(11):2050-2056. PubMed ID: 31488568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia.
    Hanas R; Adolfsson P
    Pediatr Diabetes; 2006 Feb; 7(1):25-31. PubMed ID: 16489971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for discontinuation of insulin pump therapy in pediatric and young adult patients.
    Kostev K; Rockel T; Rosenbauer J; Rathmann W
    Prim Care Diabetes; 2014 Dec; 8(4):346-51. PubMed ID: 24735947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients.
    Kapellen TM; Klinkert C; Heidtmann B; Jakisch B; Haberland H; Hofer SE; Holl RW
    Postgrad Med; 2010 May; 122(3):98-105. PubMed ID: 20463419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
    Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes.
    Lin MH; Connor CG; Ruedy KJ; Beck RW; Kollman C; Buckingham B; Redondo MJ; Schatz D; Haro H; Lee JM; Tamborlane WV; Wood JR;
    Diabetes Technol Ther; 2013 Nov; 15(11):929-34. PubMed ID: 23869706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI)].
    Olsovský J; Beránek M
    Vnitr Lek; 2007 Jun; 53(6):637-45. PubMed ID: 17702123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study.
    Scaramuzza AE; Iafusco D; Rabbone I; Bonfanti R; Lombardo F; Schiaffini R; Buono P; Toni S; Cherubini V; Zuccotti GV;
    Diabetes Technol Ther; 2011 Feb; 13(2):99-103. PubMed ID: 21284475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: A 1-year prospective observational study with suggestions to minimize clinical impact.
    Rabbone I; Minuto N; Toni S; Lombardo F; Iafusco D; Marigliano M; Schiaffini R; Maltoni G; Frongia AP; Scardapane M; Nicolucci A; Cherubini V; Bonfanti R; Scaramuzza AE;
    Diabetes Obes Metab; 2018 Nov; 20(11):2551-2556. PubMed ID: 29893044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.
    Lawson ML; Verbeeten KC; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Chan J; Tang K
    Pediatr Diabetes; 2021 Mar; 22(2):279-287. PubMed ID: 33098212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study.
    Thorius IH; Husemoen LLN; Nordsborg RB; Alibegovic AC; Gall MA; Petersen J; Mathiesen ER
    Diabetologia; 2023 May; 66(5):826-836. PubMed ID: 36640191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.
    Fendler W; Baranowska AI; Mianowska B; Szadkowska A; Mlynarski W
    Acta Diabetol; 2012 Oct; 49(5):363-70. PubMed ID: 21964866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of diabetes control in insulin pump therapy in late adolescentsand young adults with type 1 diabetes.
    Bielińska A; Niemiec A; Bryśkiewicz M; Wójcik K; Majkowska L
    Pediatr Endocrinol Diabetes Metab; 2018; 24(1):6-10. PubMed ID: 30083657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Transatlantic HbA
    Hermann JM; Miller KM; Hofer SE; Clements MA; Karges W; Foster NC; Fröhlich-Reiterer E; Rickels MR; Rosenbauer J; DeSalvo DJ; Holl RW; Maahs DM;
    Diabet Med; 2020 May; 37(5):848-855. PubMed ID: 31557351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
    Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
    Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents.
    Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):198-203. PubMed ID: 33374094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid profile is associated with treatment regimen in a large cohort of children and adolescents with Type 1 diabetes mellitus: a study from the international SWEET database.
    Kosteria I; Schwandt A; Davis E; Jali S; Prieto M; Rottembourg D;
    Diabet Med; 2019 Oct; 36(10):1294-1303. PubMed ID: 30972800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 1 Diabetes Management in the Hospital Setting.
    Granados A; Carrillo Iregui A
    Pediatr Rev; 2024 Apr; 45(4):201-209. PubMed ID: 38556511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.